Clinical Trials List
Protocol NumberCVPM087A2101
Completed
2019-04-19 - 2025-11-11
Phase I
Recruiting1
ICD-10C19
Malignant neoplasm of rectosigmoid junction
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9154.0
Malignant neoplasm of rectosigmoid junction
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Wu-Chou Su 無
- Po-Wen Lin 無
- 黃盈慈 無
- Peng-Chan Lin 無
- Jui-Hung Tsai 無
- Shang-Hung Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3-5 participants
-
Global
167 participants
